274 related articles for article (PubMed ID: 37353996)
21. A multi-objective radiomics model for the prediction of locoregional recurrence in head and neck squamous cell cancer.
Wang K; Zhou Z; Wang R; Chen L; Zhang Q; Sher D; Wang J
Med Phys; 2020 Oct; 47(10):5392-5400. PubMed ID: 32657426
[TBL] [Abstract][Full Text] [Related]
22. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
[TBL] [Abstract][Full Text] [Related]
23. Utility of SUV
Lim RS; Ramdave S; Beech P; Billah B; Karim MN; Smith JA; Safdar A; Sigston E
Cancer Imaging; 2016 Nov; 16(1):39. PubMed ID: 27821180
[TBL] [Abstract][Full Text] [Related]
24. [Correlations of
Dang HD; Chen Y; Shi XH; Hou B; Xing HQ; Zhang T; Chen XM; Zhang ZH; Xue HD; Jin ZY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Apr; 40(2):242-249. PubMed ID: 29724315
[TBL] [Abstract][Full Text] [Related]
25. Use of Diffusion-Weighted Imaging and
Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
[TBL] [Abstract][Full Text] [Related]
26. Clinical Role of Positron Emission Tomography/Computed Tomography Imaging in Head and Neck Squamous Cell Carcinoma.
Abdalla AS; Sheybani ND; Khan SA
PET Clin; 2022 Apr; 17(2):213-222. PubMed ID: 35256298
[TBL] [Abstract][Full Text] [Related]
27.
Kim SA; Roh JL; Kim JS; Lee JH; Lee SH; Choi SH; Nam SY; Kim SY
Eur J Cancer; 2017 Feb; 72():62-70. PubMed ID: 28027517
[TBL] [Abstract][Full Text] [Related]
28. 18F-FDG PET cannot predict expression of clinically relevant histopathological biomarkers in head and neck squamous cell carcinoma: a meta-analysis.
Surov A; Pech M; Eckert A; Arens C; Grosser O; Wienke A
Acta Radiol; 2022 Feb; 63(2):166-175. PubMed ID: 33541089
[TBL] [Abstract][Full Text] [Related]
29. Impact of (18)F-FDG PET/CT staging on management and prognostic stratification in head and neck squamous cell carcinoma: A prospective observational study.
Ryu IS; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Eur J Cancer; 2016 Aug; 63():88-96. PubMed ID: 27288873
[TBL] [Abstract][Full Text] [Related]
30. Prospective evaluation of the impact of human papilloma virus status and small node size on the diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for primary head and neck squamous cell carcinoma.
Lee J; Emmett L; Tang R; Ho B; Earls P; Matthews T; Gallagher R
ANZ J Surg; 2020 Jul; 90(7-8):1396-1401. PubMed ID: 32564498
[TBL] [Abstract][Full Text] [Related]
31. Combining standardized uptake value of FDG-PET and apparent diffusion coefficient of DW-MRI improves risk stratification in head and neck squamous cell carcinoma.
Preda L; Conte G; Bonello L; Giannitto C; Travaini LL; Raimondi S; Summers PE; Mohssen A; Alterio D; Cossu Rocca M; Grana C; Ruju F; Bellomi M
Eur Radiol; 2016 Dec; 26(12):4432-4441. PubMed ID: 26965504
[TBL] [Abstract][Full Text] [Related]
32. The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.
Vernooij LM; van Klei WA; Moons KG; Takada T; van Waes J; Damen JA
Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013139. PubMed ID: 34931303
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic performance of
Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R
Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822
[TBL] [Abstract][Full Text] [Related]
34. Meta-analysis of (18) fluorodeoxyglucose positron emission tomography-CT for diagnosis of lung malignancies in patients with head and neck squamous cell carcinomas.
Xi K; Xie X; Xi S
Head Neck; 2015 Nov; 37(11):1680-4. PubMed ID: 24850267
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of MTV and TLG of 18 F-FDG PET in patients with head and neck squamous cell carcinoma: A meta-analysis.
Jin A; Lin X; Yin X; Cui Y; Ma L
Medicine (Baltimore); 2022 Sep; 101(39):e30798. PubMed ID: 36181127
[TBL] [Abstract][Full Text] [Related]
36. FDG uptake in normal tissues assessed by PET during treatment has prognostic value for treatment results in head and neck squamous cell carcinomas undergoing radiochemotherapy.
Zschaeck S; Löck S; Leger S; Haase R; Bandurska-Luque A; Appold S; Kotzerke J; Zips D; Richter C; Gudziol V; Schreiber A; Zöphel K; Baumann M; Krause M
Radiother Oncol; 2017 Mar; 122(3):437-444. PubMed ID: 28222892
[TBL] [Abstract][Full Text] [Related]
37. F18-FDG PET/CT accuracy in nodal staging of head and neck squamous cell carcinoma and correlation of SUV
Piotrowicz O; Jia HN; Blazak J
J Med Imaging Radiat Sci; 2022 Dec; 53(4):599-604. PubMed ID: 36272860
[TBL] [Abstract][Full Text] [Related]
38. Construction of an enhanced computed tomography radiomics model for non-invasively predicting granzyme A in head and neck squamous cell carcinoma by machine learning.
Hang R; Bai G; Sun B; Xu P; Sun X; Yan G; Zhang W; Wang F
Eur Arch Otorhinolaryngol; 2023 Jul; 280(7):3353-3364. PubMed ID: 36920557
[TBL] [Abstract][Full Text] [Related]
39. Predictive value of suvmax changes between two sequential post-therapeutic FDG-pet in head and neck squamous cell carcinomas.
Stadler TM; Hüllner MW; Broglie MA; Morand GB
Sci Rep; 2020 Oct; 10(1):16689. PubMed ID: 33028940
[TBL] [Abstract][Full Text] [Related]
40. A computed tomography-based radiomics signature for predicting expression of programmed death ligand 1 in head and neck squamous cell carcinoma.
Zheng YM; Yuan MG; Zhou RQ; Hou F; Zhan JF; Liu ND; Hao DP; Dong C
Eur Radiol; 2022 Aug; 32(8):5362-5370. PubMed ID: 35298679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
